Connect with us

Hi, what are you looking for?

News

Keysight: Valuation Is Now Looking Good (NYSE:KEYS)

Investment Thesis

I previously covered Keysight (NYSE:KEYS) where I talked more in depth about the business model and the implied quality I think it has. In that article, I decided that the best thing was to hold at the moment and

Estimate Actual Beat/Miss
Revenue $1.20 Billion $1.22 Billion 1.0%
EBITDA $327 Million $332 Million 1.4%
EPS $1.39 $1.41 1.6%

FY2023 FY2024 Revenue change
Q1 $1,381 $1,259 -8.8%
Q2 $1,390 $1,216 -12.5%
Q3 $1,382 $1,190 -13.9%
Q4 $1,311 ? ?

Read the full article here

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

News

Follow Play Earnings CallPlay Earnings Call Disc Medicine, Inc. (IRON) Discusses ASH Conference Data Updates and Portfolio Progress Including Anemia and Iron Restriction Programs...

Videos

Watch full video on YouTube